NO20071912L - Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. - Google Patents
Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger.Info
- Publication number
- NO20071912L NO20071912L NO20071912A NO20071912A NO20071912L NO 20071912 L NO20071912 L NO 20071912L NO 20071912 A NO20071912 A NO 20071912A NO 20071912 A NO20071912 A NO 20071912A NO 20071912 L NO20071912 L NO 20071912L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- salts suitable
- donepezil
- donepezil salts
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical class O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
| PCT/HU2005/000102 WO2006030249A1 (en) | 2004-09-15 | 2005-09-12 | Donepezil salts suitable for the preparation of pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071912L true NO20071912L (no) | 2007-06-07 |
Family
ID=89985497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071912A NO20071912L (no) | 2004-09-15 | 2007-04-16 | Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080194628A1 (cs) |
| EP (1) | EP1817286A1 (cs) |
| CN (1) | CN101039910A (cs) |
| BG (1) | BG109855A (cs) |
| CZ (1) | CZ2007248A3 (cs) |
| EA (1) | EA200700637A1 (cs) |
| HU (1) | HUP0401850A3 (cs) |
| IL (1) | IL181827A0 (cs) |
| NO (1) | NO20071912L (cs) |
| PL (1) | PL382842A1 (cs) |
| RU (1) | RU2382032C2 (cs) |
| SK (1) | SK50342007A3 (cs) |
| UA (1) | UA88481C2 (cs) |
| WO (1) | WO2006030249A1 (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
| AU2005288521A1 (en) * | 2004-09-29 | 2006-04-06 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| WO2007010910A1 (en) * | 2005-07-15 | 2007-01-25 | Eisai R & D Management Co., Ltd. | 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
| WO2007108011A2 (en) * | 2006-03-20 | 2007-09-27 | Ind-Swift Laboratories Limited | Process for the preparation of highly pure donepezil |
| GB0609835D0 (en) * | 2006-05-18 | 2006-06-28 | Pliva Istrazivanje I Razvoj D | Impurities of a pharmaceutical product |
| EP2204364B1 (en) * | 2007-09-28 | 2013-03-20 | Tianjin Hemay Bio-Tech Co., Ltd. | Polymorphs of donepezil salts, preparation methods and uses thereof |
| WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
| US20140243278A1 (en) * | 2011-07-05 | 2014-08-28 | Sunil Sadanand Nadkarni | Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof |
| EP2586436A1 (en) | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
| WO2013078608A1 (en) | 2011-11-29 | 2013-06-06 | Ziqiang Gu | Donepezil pamoate and methods of making and using the same |
| KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
| WO2018153315A1 (zh) * | 2017-02-23 | 2018-08-30 | 上海华汇拓医药科技有限公司 | 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法 |
| EP3888636A4 (en) * | 2018-11-26 | 2022-08-17 | Ebabio Inc. | EUTECTIC MIXTURE OF DONEPEZIL AND ITS USE |
| CN120058592B (zh) * | 2023-11-28 | 2026-06-26 | 广东东阳光药业股份有限公司 | 多奈哌齐衍生物的盐及其在药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| AU731282B2 (en) * | 1996-06-07 | 2001-03-29 | Eisai Co. Ltd. | Polymorphs of donepezil hydrochloride and process for production |
| US6372760B1 (en) * | 1999-03-31 | 2002-04-16 | Eisai Co., Ltd. | Stabilized composition comprising antidementia medicament |
| ES2284519T3 (es) * | 1999-09-01 | 2007-11-16 | EISAI R&D MANAGEMENT CO., LTD. | Derivados de piperidina 4-sustituida. |
| EP1285656A4 (en) * | 2000-04-13 | 2006-07-12 | Eisai Co Ltd | ACETYLCHOLINESTERASE HEMMER CONTAINING 1-BENZYLPYRIDINIUM SALT |
| US7439365B2 (en) * | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
-
2004
- 2004-09-15 HU HU0401850A patent/HUP0401850A3/hu unknown
-
2005
- 2005-09-12 RU RU2007114082/04A patent/RU2382032C2/ru not_active IP Right Cessation
- 2005-09-12 SK SK5034-2007A patent/SK50342007A3/sk not_active Application Discontinuation
- 2005-09-12 CN CNA2005800348076A patent/CN101039910A/zh active Pending
- 2005-09-12 WO PCT/HU2005/000102 patent/WO2006030249A1/en not_active Ceased
- 2005-09-12 CZ CZ20070248A patent/CZ2007248A3/cs unknown
- 2005-09-12 EP EP05787910A patent/EP1817286A1/en not_active Withdrawn
- 2005-09-12 UA UAA200704106A patent/UA88481C2/ru unknown
- 2005-09-12 EA EA200700637A patent/EA200700637A1/ru unknown
- 2005-09-12 PL PL382842A patent/PL382842A1/pl not_active Application Discontinuation
- 2005-12-09 US US11/662,867 patent/US20080194628A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181827A patent/IL181827A0/en unknown
- 2007-04-13 BG BG109855A patent/BG109855A/bg unknown
- 2007-04-16 NO NO20071912A patent/NO20071912L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ2007248A3 (cs) | 2007-06-20 |
| HU0401850D0 (en) | 2004-11-29 |
| PL382842A1 (pl) | 2008-01-21 |
| WO2006030249A1 (en) | 2006-03-23 |
| EP1817286A1 (en) | 2007-08-15 |
| HUP0401850A3 (en) | 2008-03-28 |
| US20080194628A1 (en) | 2008-08-14 |
| CN101039910A (zh) | 2007-09-19 |
| RU2007114082A (ru) | 2008-10-27 |
| HUP0401850A2 (en) | 2006-11-28 |
| RU2382032C2 (ru) | 2010-02-20 |
| SK50342007A3 (sk) | 2007-07-06 |
| IL181827A0 (en) | 2007-07-04 |
| UA88481C2 (ru) | 2009-10-26 |
| BG109855A (bg) | 2008-04-30 |
| EA200700637A1 (ru) | 2007-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055496L (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
| CY1117667T1 (el) | 3,4-διαρυλπυραζολια ως αναστολεις κινασης πρωτεϊνης | |
| DE60323090D1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
| EA200700387A1 (ru) | Гидраты и полиморфы 4-[[(7r)-8-циклопентил-7-этил-5,6,7,8-тетрагидро-5-метил-6-оксо-2-птеридинил]амино]-3-метокси-n-(1-метил-4-пиперидинил)бензамида, способы их получения и их применение в качестве лекарственных средств | |
| NZ597059A (en) | Inhibitors of influenza viruses replication | |
| TN2009000070A1 (en) | Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors | |
| WO2005005414A3 (en) | Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| MX2009003985A (es) | Fenil-acetamidas utiles como inhibidores de cinasa de proteina. | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| ATE396986T1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| NO20054763L (no) | Salter av clopidogrel og fremgangsmate for fremstilling derav | |
| UA88481C2 (ru) | Донепезила фумарат, пригодный для получения фармацевтических композиций | |
| EA200401319A1 (ru) | Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине | |
| SE0950390L (sv) | System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför | |
| ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
| CY1112638T1 (el) | Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον | |
| TW200612922A (en) | Inhibitors of hsp90 | |
| NO20053809L (no) | Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav | |
| ATE435864T1 (de) | Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2- aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln | |
| NO20073132L (no) | Fremstilling av proteiner | |
| NO20056042L (no) | Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse | |
| WO2004009028A3 (en) | Method and composition for treating and preventing influenza infection and symptoms thereof | |
| NO20056005L (no) | Terapautiske midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |